Revalia Bio
- Website
- revaliabio.com
- Total Funding
- $14.5M
- Last Round
- $14.5M SeedSep 2025
- Rounds
- 1
About
We're using AI to transform donated human organs & tissues into high-fidelity biological data, shared insight, and faster decisions.
Summary
Revalia Bio is a Biotech company. It has raised $14.5M in total across 1 round, most recently a $14.5M Seed round in Sep 2025. Investors include America's Frontier Fund and Sierra Ventures.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sep 2025
Investors
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/revalia-bio"><img src="https://indexed.vc/api/badge/company/revalia-bio" alt="Revalia Bio on Indexed.vc" width="260" height="76" /></a>